Oxogestone phenpropionate
Identifiers | |
---|---|
| |
CAS Number | 16915-80-3 |
PubChem (CID) | 20055360 |
ChemSpider | 16736681 |
UNII | 7IA4J676HM |
KEGG | D05308 |
ChEMBL | CHEMBL2107303 |
Chemical and physical data | |
Formula | C29H38O3 |
Molar mass | 434.61022 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Oxogestone phenpropionate (USAN), also known as (20R)-3-oxo-19-norpregn-4-en-20-yl 3-phenylpropanoate, is a steroidal progestin related to the 19-norprogesterone derivatives that was developed as an injectable hormonal contraceptive in the 1960s and early 1970s but was never marketed.[1][2] It is the 3-phenylpropionate derivative of oxogestone, which, similarly, was never marketed.[1]
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 919–. ISBN 978-1-4757-2085-3.
- ↑ van der Vies, J. (1970). "Model studies in vitro with long-acting hormonal preparations". Acta Endocrinologica. 64 (4): 656–669. doi:10.1530/acta.0.0640656. ISSN 0804-4643. PMID 5468664.
This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.